← Back to Clinical Trials
Recruiting NCT05492188

NCT05492188 Neuropathic Pain and Operant Conditioning of Cutaneous Reflexes After SCI

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05492188
Status Recruiting
Phase —
Sponsor Medical University of South Carolina
Condition Spinal Cord Injuries
Study Type INTERVENTIONAL
Enrollment 15 participants
Start Date 2023-03-27
Primary Completion 2027-01-15

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Operant Conditioning of Cutaneous Reflexes

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 15 participants in total. It began in 2023-03-27 with a primary completion date of 2027-01-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of the second part of the study is to examine the effect of reflex training in the leg to decrease neuropathic pain. For this, the researchers are recruiting 15 individuals with neuropathic pain due to spinal cord injury to participate in the reflex training procedure. The study involves approximately 50 visits with a total study duration of about 6.5 months (3 months for baseline and training phases followed by 1 month and 3 month follow-up visits).

Eligibility Criteria

Inclusion Criteria: 1. neurologically stable (\>1 year post SCI) 2. medical clearance to participate 3. ability to stand with or without an assistive device for at least 3 minutes at a time 4. expectation that current medication will be maintained without change for at least 3 months (stable use of anti-spasticity medication is accepted) 5. For participants with neuropathic pain, the area of neuropathic pain must include lower leg. Exclusion Criteria: 1. motoneuron injury 2. known cardiac condition 3. medically unstable condition (incl. pregnancy) 4. cognitive impairment 5. uncontrolled peripheral neuropathy 6. frequent use of electrical spinal stimulation (either transcutaneous or epidural) for pain treatment 7. daily use of electrical stimulation to the leg 8. complete lack of cutaneous sensation around foot.

Contact & Investigator

Central Contact

Blair Dellenbach, MSOT

✉ stecb@musc.edu

📞 843-792-6313

Principal Investigator

Aiko Thompson, PhD

PRINCIPAL INVESTIGATOR

Medical University of South Carolina

Frequently Asked Questions

Who can join the NCT05492188 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Spinal Cord Injuries. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05492188 currently recruiting?

Yes, NCT05492188 is actively recruiting participants. Contact the research team at stecb@musc.edu for enrollment information.

Where is the NCT05492188 trial being conducted?

This trial is being conducted at Charleston, United States.

Who is sponsoring the NCT05492188 clinical trial?

NCT05492188 is sponsored by Medical University of South Carolina. The principal investigator is Aiko Thompson, PhD at Medical University of South Carolina. The trial plans to enroll 15 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology